Other Liabilities - Gensight Biologics SA (PAR:SIGHT) - Alpha Spread

Gensight Biologics SA
PAR:SIGHT

Watchlist Manager
Gensight Biologics SA Logo
Gensight Biologics SA
PAR:SIGHT
Watchlist
Price: 0.38 EUR -3.8%
Market Cap: 39.3m EUR
Have any thoughts about
Gensight Biologics SA?
Write Note

Gensight Biologics SA
Other Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Gensight Biologics SA
Other Liabilities Peer Comparison

Comparables:
VLA
NANO
IPH
GNFT
ALERS

Competitive Other Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Other Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Gensight Biologics SA
PAR:SIGHT
Other Liabilities
€8.4m
CAGR 3-Years
53%
CAGR 5-Years
160%
CAGR 10-Years
N/A
Valneva SE
PAR:VLA
Other Liabilities
€7m
CAGR 3-Years
-60%
CAGR 5-Years
-2%
CAGR 10-Years
-7%
Nanobiotix SA
PAR:NANO
Other Liabilities
€2.2m
CAGR 3-Years
-13%
CAGR 5-Years
45%
CAGR 10-Years
36%
Innate Pharma SA
PAR:IPH
Other Liabilities
€6.9m
CAGR 3-Years
-40%
CAGR 5-Years
-36%
CAGR 10-Years
15%
Genfit SA
NASDAQ:GNFT
Other Liabilities
€4.7m
CAGR 3-Years
-1%
CAGR 5-Years
2%
CAGR 10-Years
0%
Eurobio Scientific SA
PAR:ALERS
Other Liabilities
€2.2m
CAGR 3-Years
-1%
CAGR 5-Years
-3%
CAGR 10-Years
2%

See Also

What is Gensight Biologics SA's Other Liabilities?
Other Liabilities
8.4m EUR

Based on the financial report for Dec 31, 2023, Gensight Biologics SA's Other Liabilities amounts to 8.4m EUR.

What is Gensight Biologics SA's Other Liabilities growth rate?
Other Liabilities CAGR 5Y
160%

Over the last year, the Other Liabilities growth was -25%. The average annual Other Liabilities growth rates for Gensight Biologics SA have been 53% over the past three years , 160% over the past five years .

Back to Top